Monday 19 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 30 days ago

Roche s Tecentriq boosts survival in triple-negative breast cancer

An immunotherapy cocktail from Roche helped slow a type of breast cancer where new treatments have proven elusive, data released on Saturday showed, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.

Related news

Latest News
Hashtags:   

Roche

 | 

Tecentriq

 | 

boosts

 | 

survival

 | 

triple

 | 

negative

 | 

breast

 | 

cancer

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources